Q&A Series: The world is rearming at a record pace – so why have defence stocks stalled?

In the latest edition of our Q&A series, we talked to VanEck to learn more about the VanEck Defense UCITS ETF.

iFAST Research Team
iFAST Research Team29 May 2026 604 Views
Q&A Series: The world is rearming at a record pace – so why have defence stocks stalled?

Global military spending continues to climb as governments respond to a more fragmented and uncertain geopolitical environment. The US is considering a larger defence budget under President Trump, while NATO members are ramping up spending to strengthen their own defence capabilities and reduce reliance on Washington. At the same time, conflicts in Ukraine and the Middle East have underscored the need to replenish depleted ammunition stockpiles, modernise weapons systems and expand defence industrial capacity. Against this backdrop, investors are increasingly looking at defence as a long-term structural growth theme.

In this article, we share insights from VanEck on the global defence landscape, and what responsible investing in defence looks like today.

Introducing the VanEck Defense UCITS ETF

The VanEck Defence UCITS ETF (LSE: DFNS) provides diversified exposure to the global defence industry at a time of unprecedented rearmament. Tracking the MarketVector™ Global Defence Industry Index, it invests across the full spectrum of modern defence – from traditional aerospace and munitions manufacturers to cybersecurity software and unmanned vehicles.

Table 1: Key information about the ETF

ETF Details

Underlying Index

MarketVector™ Global Defense Industry Index

Base Currency

USD

Trading Currency

USD

LSE Code

DFNS

Listing Date

31 March 2023

Number of Holdings

40

Assets Under Management

USD 8.5 Billion

Trading Board Lot Size

1 unit

Expense Ratio

0.55%

Dividend Distribution Frequency

None

Source: VanEck. Data as of 28 May 2026

1. Do you view the current surge in global defence spending as a temporary response to recent geopolitical conflicts (e.g. Russia–Ukraine war, US–Iran tensions), or a permanent structural shift in global fiscal priorities?

We see it as a structural shift, and the distinction matters for how investors should think about the sector's long-term return profile.

The catalyst may have been geopolitical shocks, particularly Russia's full-scale invasion of Ukraine in 2022, the escalation of Middle East tensions, and the broader realignment of US foreign policy under the Trump administration, but the spending response has now been institutionalised through binding multi-year commitments. In June 2025, all 32 NATO members agreed to raise defence spending to 5% of GDP by 2035, more than doubling the prior 2% benchmark. Germany passed its €100bn Sondervermögen, France updated its multi-year LPM, and Poland is now spending above 4% of GDP. Using NATO methodology, all members reached the previous 2% target, for the first time. These are legislative commitments, not discretionary budget lines. They do not reverse if a conflict de-escalates.

The structural case also goes beyond any single conflict. Decades of underinvestment across NATO have left European armed forces with depleted equipment inventories, ageing platforms, and insufficient ammunition stockpiles. Global munitions supplies have been depleted by a series of conflicts, adding to pressure on governments to rebuild inventories. Rebuilding those stockpiles and modernising to meet current threat environments, air and missile defence, autonomous systems, cyber, space, is a decade-long programme regardless of what happens in Ukraine or Iran.

The principal risk to this thesis is not a peace agreement, as contracted backlogs are resilient to that. The risk is a sustained shift in political priorities: a reordering of fiscal budgets under austerity pressure, or a generational change in voters' willingness to fund defence. That is rather a medium-to-long-term tail risk, not a near-term one.

2. DFNS’ performance has been relatively flat year-to-date. Why haven’t defence stocks reacted more strongly to heightened geopolitical tensions over the past year?

DFNS is up approximately +1.1% year-to-date as of 19 May 2026, broadly flat, despite an extraordinary geopolitical backdrop that includes ongoing US operations in Iran, continued fighting in Ukraine, and NATO rearmament at historic pace. The underperformance relative to the macro narrative is an important question, and we think several forces explain it.

First, this is a classic "buy the rumour, sell the war" dynamic. Share prices of leading American defence primes have all fallen since the US bombed Iran at the end of February, despite the military's massive expenditure of ordnance drawing attention to mounting production backlogs. Stocks like Lockheed Martin, Northrop Grumman, and RTX had already re-rated 50% or more in the 12 months prior to the conflict's outbreak, much of the geopolitical risk premium had been priced in. Lockheed Martin, Northrop Grumman, and RTX's stock all increased by about 50% in the year up to the outbreak of the conflict, powered by Trump's budget request boosting defence spending, as well as ongoing turmoil in Ukraine and the Middle East.

Second, markets have focused on a structural constraint: "The top-line growth for these defence companies is not going to be constrained by demand, but by capacity1," as Bank of America's defence analyst noted. The US has burned through munitions faster than they can be replenished. Revenue recognition only occurs on delivery and not on order, so elevated conflict activity increases backlogs, but does not accelerate near-term earnings.

Third, there is meaningful budget uncertainty. Trump's $1.5tn budget proposal might have not been priced in because investors know there is a long way to go, it is an unpredictable process, compounded by midterm elections.

Finally, some of the Q1 earnings disappointed. Rheinmetall's Q1 results fell significantly short on revenue and EPS due to delivery timing issues, and markets, having priced these names for near-perfect execution, responded harshly.

In our view, the fundamentals for the sector remain intact. The current flat performance reflects a consolidation and re-rating of elevated multiples, not a deterioration in the demand outlook.


https://www.ft.com/content/1c9c4694-2ed3-4aac-8f64-2cbc5fb0e7cc?syn-25a6b1a6=1

3. Which regions currently offer the most attractive investment opportunities within the global defence sector?

DFNS holds a global portfolio with a good split between US, European producers and Asian and we think that diversification is currently an advantage rather than a risk, given regional divergences in performance.

South Korea has been the standout in recent months. Hanwha Aerospace, Hanwha Systems, Korea Aerospace Industries, and Hyundai Rotem collectively accounted for virtually all the positive attribution in the portfolio during April–May 2026. Korean defence companies are benefiting from a combination of competitive export pricing, rapid production scale-up, and growing demand from European buyers seeking to diversify away from US supply chains.

Europe remains the most compelling structural growth story over the medium term. Government spending commitments are largest and accelerating here, and European primes have backlogs at record levels. The near-term underperformance of names like Saab, Leonardo, and Thales reflects valuation consolidation after a very strong 2024–2025 run, not a deterioration in fundamentals.

The US remains the largest weight in the portfolio and offers unparalleled revenue scale and programme diversification, but is also facing the most near-term headwinds from earnings execution concerns, programme delays, and budget process uncertainty.

Israel offers concentrated exposure to air and missile defence, UAVs, and electronic warfare through Elbit Systems and Next Vision Stabilized, sub-sectors with strong structural demand given the threat environment.

4. Could you walk us through the different sub-sectors within defence and explain how DFNS is positioned across these areas?

The MarketVector Global Defense Index uses eight proprietary thematic classifications to capture the full spectrum of modern defence. Based on the Q1 2026 portfolio, the breakdown is approximately as follows:

Aerospace & Defence Products & Services (~72% of portfolio weight) is the largest bucket and covers traditional prime contractors and platform manufacturers — aircraft, armoured vehicles, naval systems, missiles, and ammunition. Key holdings include RTX, Thales, Leonardo, Hanwha Aerospace, Saab, Elbit Systems, and Dassault Aviation.

Event Response, Security & Safety Software (~21%) captures companies providing software for situational awareness, command and control, and crisis management. Palantir is the flagship name here; Leidos, CACI, and Parsons also sit in this theme.

Communications Systems & Services (~16%) covers secure military communications, datalinks, and networks. Thales, Saab, Kratos, and Leidos feature prominently.

IT Hardware & Services (~16%) includes companies providing defense-grade computing infrastructure, sensors, and electronics. Leidos, Hensoldt, Mercury Systems, and Leonardo DRS.

Cybersecurity (~8%) is a growing theme with Hensoldt, Leidos, Parsons, and SAIC as key representatives. This sub-theme reflects the increasing digitisation of conflict and the growing importance of network defence.

Unmanned Vehicles (~9%) is the fastest-growing thematic area, covering drones, UGVs, and autonomous platforms. Holdings include AeroVironment, Kratos, Ondas Holdings, CSG NV, and DroneShield, a cluster of names that performed strongly during the Iran conflict as drone warfare attracted significant investor attention. In fact, all defense majors are currently involved in unmanned vehicles in some kind of way. Some more than another.

Training & Simulation (~7%) covers companies providing mission rehearsal and training systems, Kratos, Korea Aerospace Industries, and Babcock International.

Digital Forensics & Detection (<1%) is a small but distinctive allocation covering biometric identification and threat detection, OSI Systems is the primary representative.

The portfolio's weighted average defence revenue exposure stands at approximately 65%, meaning that two-thirds of revenues across holdings are derived directly from defense-related activities.
 

5. For investors who feel uncomfortable allocating to defence on ethical or ESG grounds, what is your response? Are there any categories of weapons that the ETF explicitly excludes?

We take this concern seriously and recognise that defence sits at one of the more contested intersections of ESG and thematic investing. Our position is that defence investment, when properly scoped, might be consistent with responsible investment principles, and that the ESG conversation around defence has evolved meaningfully since Russia's 2022 invasion of Ukraine.

On exclusions: DFNS applies hard exclusions for companies with material involvement in cluster munitions, anti-personnel mines, biological and chemical weapons, depleted uranium, white phosphorus and nuclear weapons outside of the Non-Proliferation Treaty framework. These exclusions are applied at the index level through ISS ESG screening data and are applied in all rebalancing reviews. Additionally, ISS Norm Based research score is used to exclude companies involved in controversies or violating UN Global Compact principles as well as OECD guidelines for multinational enterprises.

There is a growing number of European institutional investors investing in defence companies considering this mindset change.

6. How does DFNS differ from other global defence ETFs in terms of index methodology, performance, and overall portfolio exposure?

The three main UCITS peers are HANetf Future of Defence (NATO), iShares Global Aerospace & Defence (DFND), and Global X Defence Tech (DFEN). Here is how we see the key distinctions:

DFNS vs. HANetf Future of Defence (NATO): HANetf tracks the EQM NATO+ Future of Defence Index. DFNS has established itself as the larger and the most well-known defense product in Europe. DFNS offers broader geographic scope and less exposure to non-defense related sectors like commercial cybersecurity.

DFNS vs. iShares Global Aerospace & Defence (DFND): DFND tracks the S&P Developed BMI Select Aerospace & Defense Index, which is a more traditional aerospace-and-defence benchmark that includes commercial aerospace (Boeing, Airbus, and their supply chains) alongside pure-play defence. This results in a more diluted pure-play defence exposure.

DFNS vs. Global X Defence Tech (DFEN): Global X takes a technology-forward approach, with heavier weighting toward defence software, AI, and dual-use technology names. DFNS offers more balanced exposure between traditional primes and emerging tech, providing more resilience when tech sentiment de-rates.

The core differentiator for DFNS is the combination of global geographic scope (including Korea and Israel), pure-play defense revenue focus, and multi-thematic construction that captures the full spectrum of modern defense — from platforms and munitions through to cyber, and autonomous systems.


FOR INSTITUTIONAL/PROFESSIONAL INVESTORS ONLY. NOT FOR USE WITH THE GENERAL PUBLIC.

Singapore investors
The offer or invitation of the Shares/Units of the respective VanEck fund (the “Fund”), which is the subject of this material, does not relate to a collective investment scheme which is authorised under section 286 of the Securities and Futures Act, Chapter 289 of Singapore (the “SFA”) or recognised under section 287 of the SFA. The Fund is not authorised or recognised by the Monetary Authority of Singapore (the “MAS”) and Shares/Units are not allowed to be offered to the retail public.

This material has not been registered as a prospectus with the MAS. Accordingly, this material and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of Shares/Units may not be circulated or distributed, nor may Shares/Units be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than to (i) an institutional investor under Section 304 of the SFA, or (ii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA. Resale restrictions apply to interests of funds acquired pursuant to Section 304 or Section 305.

The Fund may only be promoted exclusively to persons who are sufficiently experienced and sophisticated to understand the risks involved in investing in the Fund, and who satisfy certain other criteria provided under Sections 304 or 305 of the SFA and the subsidiary legislation enacted thereunder. This material is for general information purposes only and should not be regarded as a prospectus as defined in the SFA or information memorandum nor forming part thereof. Accordingly, statutory liability under the SFA in relation to the content of prospectuses would not apply. In Singapore, this material may only be distributed together with the prospectus or information memorandum, which must be referred to for information on the Fund.

Important information
Nothing in this content should be considered a solicitation to buy or an offer to sell shares of any investment in any jurisdiction where the offer or solicitation would be unlawful under the securities laws of such jurisdiction, nor is it intended as investment, tax, financial, or legal advice. Investors should seek such professional advice for their particular situation and jurisdiction.
NOT FOR USE IN THE UNITED STATES.

All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.

Please read our full disclaimers on the website at ( https://secure.fundsupermart.com/fsmone/policies/328125/investment-account-terms-&-conditions).

iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.